Sujun W. Zheng

Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 131 publications

Corrigendum to "A HRG novel mutation associated with idiopathic portal hypertension: Case report and literature review" [iLIVER 1 (2022) 90-95].

Corrigendum to "A HRG novel mutation associated with idiopathic portal hypertension: Case report and literature review" [iLIVER 1 (2022) 90-95].

Journal: iLIVER
Published: February 02, 2026

Response to letter-Machine learning prediction of rapid HBsAg seroclearance at week 24 in inactive carriers treated with pegylated interferon.

Response to letter-Machine learning prediction of rapid HBsAg seroclearance at week 24 in inactive carriers treated with pegylated interferon.

Journal: Hepatology international
Published: January 10, 2026

Response to letter to editor-Machine learning prediction of rapid HBsAg seroclearance at week 24 in inactive carriers treated with pegylated interferon.

Response to letter to editor-Machine learning prediction of rapid HBsAg seroclearance at week 24 in inactive carriers treated with pegylated interferon.

Journal: Hepatology international
Published: January 10, 2026

A combined model of HBcrAg, anti-HBc, and anti-HBs predicts recurrence after functional cure of chronic hepatitis B.

A combined model of HBcrAg, anti-HBc, and anti-HBs predicts recurrence after functional cure of chronic hepatitis B.

Journal: Hepatology international
Published: November 27, 2025

Incidence and predictors of HBsAg loss following addition of pegylated interferon Alfa-2b in chronic hepatitis B patients suppressed by nucleos(t)ide analogues: a multicenter, prospective, cohort study.

Incidence and predictors of HBsAg loss following addition of pegylated interferon Alfa-2b in chronic hepatitis B patients suppressed by nucleos(t)ide analogues: a multicenter, prospective, cohort study.

Journal: Virology journal
Published: November 03, 2025

HBV RNA at 6 months after nucleos(t)ide analogues treatment can predict antiviral efficacy in chronic hepatitis B patients.

HBV RNA at 6 months after nucleos(t)ide analogues treatment can predict antiviral efficacy in chronic hepatitis B patients.

Journal: BMC gastroenterology
Published: October 01, 2025

Safety and efficacy of PD-1 antibody combined with pegylated interferon α for functional cure in nucleos(t)ide analogues-suppressed chronic hepatitis B patients: protocol for a multicentre randomised controlled trial.

Safety and efficacy of PD-1 antibody combined with pegylated interferon α for functional cure in nucleos(t)ide analogues-suppressed chronic hepatitis B patients: protocol for a multicentre randomised controlled trial.

Journal: BMJ open
Published: September 21, 2025

Defining success in functional cure for chronic hepatitis B: a nationwide survey of physician benchmarks to guide clinical practice and trial design.

Defining success in functional cure for chronic hepatitis B: a nationwide survey of physician benchmarks to guide clinical practice and trial design.

Journal: Frontiers in public health
Published: September 17, 2025

Global burden of Wilson disease: a comprehensive evidence synthesis.

Global burden of Wilson disease: a comprehensive evidence synthesis.

Journal: Orphanet journal of rare diseases
Published: September 12, 2025

Type I unconventional protein secretion of the SARS-CoV-2 nucleocapsid protein promotes inflammatory cytokine release.

Type I unconventional protein secretion of the SARS-CoV-2 nucleocapsid protein promotes inflammatory cytokine release.

Journal: Cell reports
Published: September 04, 2025

Expert Consensus on the Diagnosis and Management of Inherited Hyperbilirubinemia (2025).

Expert Consensus on the Diagnosis and Management of Inherited Hyperbilirubinemia (2025).

Journal: Journal of clinical and translational hepatology
Published: August 26, 2025

Leveraging hepatitis B vaccination to consolidate functional cure: reigniting the humoral axis in chronic HBV infection.

Leveraging hepatitis B vaccination to consolidate functional cure: reigniting the humoral axis in chronic HBV infection.

Journal: Emerging microbes & infections
Published: August 13, 2025
Showing 1-12 of 131

Last Updated: 09/26/2026